MedTrace Logo

ATHNdataset Registry

NCT06820515 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2026-04-21

No results posted yet for this study

Summary

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems.

Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.

Conditions

Sponsors & Collaborators

  • American Thrombosis and Hemostasis Network

    lead NETWORK

Principal Investigators

  • Tammuella Chrisentery-Singleton, M.D. · American Thrombosis and Hemostasis Network

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-25
Primary Completion
2054-10-25
Completion
2055-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06820515 on ClinicalTrials.gov